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The article by Goronzy et al. (6) addresses the paradox of an 
age-dependent decline in immune responses while autoimmune 
diseases increase in incidence. The authors hypothesize that the 
same defects that account for the decreased ability to generate 
protective immune responses also contribute to the increased risk 
of autoimmunity. The major risk factor for autoimmunity in old 
age appears to be the reshaping of the peripheral T cell receptor 
repertoire, which is driven by the age-dependent involution of the 
thymus. The consequent increase in homeostatic T cell prolifera-
tion prolongs peripheral T cell survival and selects for self antigen 
and cytokine responsiveness, thereby facilitating the generation of 
autoreactive T cells. Fulop et al. (7) review longitudinal studies that 
analyzed immune parameters predictive of survival. These studies 
defined an immune risk profile and showed that persistent viral 
infections, in particular Cytomegalovirus infection, can accelerate 
human T cell aging.
In an opinion article, Aspinall and Lang (8) focus on the impact 
of influenza virus infection in the elderly and highlight the current 
problems of designing a more effective vaccine for people older 
than 60 years of age. The authors propose a portfolio approach and 
emphasize that future developments should move toward a more 
personalized treatment regimen that may even be combined with 
therapeutic approaches that target immune aging itself. In another 
opinion article, Flavell and colleagues (9) accentuate the need to 
define a robust set of markers of T cell aging. The authors sum-
marize our current knowledge about markers of T cell aging and 
emphasize the lack of data about T cell phenotypes and functions 
in various human organs and tissues, which would be important 
to better understand the fate of different T cell types and the role 
of specific markers. Eventually, the identification of a set of mark-
ers for immunosenescence would be a valuable clinical tool and 
would allow to evaluate potential therapeutic interventions aiming 
to prevent or reverse immune cell aging, and to personalize vac-
cination strategies for elderly people at risk, thereby increasing life 
and health span.
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Increasing age has been associated with an insufficient protection 
following vaccination and an increased incidence and severity of 
infectious diseases. The predicted acceleration of global population 
aging will accentuate the need to understand the mechanisms that 
drive the age-related decline of the immune system and to, eventually, 
identify strategies to improve immune function in elderly people. 
One type of immune cell appears to be most dramatically affected by 
the aging process: T lymphocytes. As T lymphocytes are key players 
of the adaptive immune system, this research topic summarizes our 
current understanding on how aging affects the microenvironmental 
niches and molecular networks that are important for the generation, 
survival and function of naïve, memory and effector T lymphocytes.
Age-related changes of the bone marrow and the thymus micro-
environment lead to a decreased thymic output of functional, naïve 
T lymphocytes. The article by Palmer (1) suggests that the thymic 
stroma is a key factor in regulating thymic atrophy and that both, 
intrinsic and extrinsic factors contribute to the age-related decline 
in thymopoiesis. Several studies also demonstrate that the kinetics 
of the involution of the thymus is not uniform throughout life but 
can be divided into distinct phases, which are probably controlled 
by different molecular mechanisms.
The article by Chen et al. (2) provides an extensive review about 
how aging affects genome-wide transcriptional changes in differ-
ent cell types, such as thymocytes, CD4 and CD8 T cell subsets in 
mice and humans. Gene networks and signaling pathways that are 
altered in aged T cells are highlighted and they may prove useful 
to select robust biomarkers of T cell aging. Moro-Garcia et al. (3) 
address the impact of aging on the phenotype and function of 
naïve, memory, and highly differentiated CD4+ T cells. The authors 
also propose that the homeostatic cytokine interleukin (IL)-15 can 
rescue functional properties of highly differentiated CD4+CD28− T 
cells that accumulate in elderly people.
The impact of aging on a clinically highly relevant T cell subset, 
namely regulatory T cells (Treg), is reviewed by Fessler et al. (4). The 
authors discuss how aging affects Treg cell generation, homeostasis, 
diversity, and function. The review article also highlights the need 
to address the gaps in our understanding of Treg cell aging. This 
will be of relevance when it comes to implementing adoptive Treg 
cell therapies to treat autoimmune diseases in older individuals. 
The impact of aging on Treg cells is also addressed by an original 
article by Raynor et al. (5). The authors show that serum IL-2 levels 
decline during aging, which is associated with the accumulation of a 
unique CD25lo Bimlo FoxP3+ Treg  population in old mice. Although 
the mechanism of the age-dependent decline in Bim expression in 
Treg cells remains to be determined, the accumulation of CD25lo 
Bimlo Treg cells in old mice seems to be mediated by IL-15.
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